ArticleEnvironmental science & technology2026
Understanding and Reporting PFAS Exposure: Wide-Scope Retrospective Suspect Screening of High-Resolution Mass Spectrometry Data from Exposomics Studies.
Article in Environmental science & technology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Per- and polyfluoroalkyl substances (PFAS) comprise thousands of persistent and structurally diverse chemicals that contribute to chronic human exposure. Yet, routine biomonitoring targets only a limited set of regulated legacy compounds, underestimating overall exposure. We present a retrospective, wide-scope suspect screening analysis framework to extract PFAS information from archived LC-HRMS exposomics datasets. A curated list of 1,666 PFAS, filtered for reversed-phase LC compatibility and enriched with structural descriptors, predicted retention indices, and MS2 fragments, was used to reprocess two human biomonitoring studies involving firefighter serum pools and population-based plasma samples. Candidate features were prioritized using precursor accuracy, isotopic patterns, and MS2 similarity, followed by spectral quality filtering and retention time-index regression models based on isotopically labeled standards, reinforcing identification confidence. The reanalysis recovered up to 80% of previously reported PFAS while revealing overlooked high-confidence carboxylic, sulfonic, and sulfonamidoacetic acid homologues, and >30 tentative PFAS series, encompassing isomeric clusters (alcohols and ethers) and structurally distinct subclasses (alkylpyrimidine PFAS). The reanalysis framework also revealed shared homologue patterns across exposure contexts. By framing PFAS chemical space and providing a reusable repository of confirmed and tentative structures, this framework reinterprets HRMS biobanked data, improving PFAS pattern assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.